Add like
Add dislike
Add to saved papers

Effect of sandblasting, etching and resin bonding on the flexural strength/bonding of novel glass-ceramics.

Dental Materials 2018 October
OBJECTIVES: To process novel leucite glass-ceramics and test the effects of surface treatment and resin bonding on the biaxial flexural strength (BFS) and shear bond strength (SBS).

METHODS: Alumino-silicate glasses were ball-milled, and heat treated to form leucite glass-ceramics (LG-C, OLG-C), then sintered into ingots. Ingots were heat extruded into a refractory mould to form disc specimens (1.3×14mm diameter). IPS e.max® was used as a commercial comparison. Glass-ceramic test groups were sandblasted (Groups. 1, 4, 6), sandblasted, etched and adhesively bonded (Groups. 2, 5, 7) or lapped, etched and adhesively bonded (Groups. 3, 8). Specimens were adhesively bonded with Monobond S, followed by the application of Variolink II® cement and light curing. BFS testing was at 1mm/min and SBS testing at 0.5mm/min. Samples were characterised using XRD, SEM and profilometry.

RESULTS: XRD confirmed tetragonal leucite in LG-C/OLG-C and lithium disilicate/lithium orthophosphate in IPS e.max® . Mean BFS (MPa (SD)) were: Gp1 LG-C; 193.1 (13.9), Gp2 LG-C; 217.7 (23.0), Gp3 LG-C; 273.6 (26.7), Gp4 OLG-C; 255.9 (31); Gp5 OLG-C; 288.6 (37.4), Gp6 IPS e.max® ; 258.6 (20.7), Gp7 IPS e.max® ; 322.3 (23.4) and Gp8 IPS e.max® ; 416.4 (52.6). The Median SBS (MPa) were Gp1 LG-C; 14.2, Gp2 LG-C (10s etch); 10.6 and Gp3 IPS e.max® ; 10.8. Mean surface roughness was 5-5.1μm (IPS e.max® ) and 2.6μm (LG-C).

SIGNIFICANCE: Novel leucite glass-ceramics with reduced flaw size and fine microstructures produced enhanced BFS and SBS by resin bonding. These properties may be useful for the fabrication of minimally invasive aesthetic and fracture resistant restorations.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app